Virtus ETF Advisers
PRAX icon

Virtus ETF Advisers’s Praxis Precision Medicines PRAX Stock Holding History

Virtus ETF Advisers’s Portfolio PRAX Stock Details PRAX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$322K Buy
1,105
+222
+25% +$73.5K 0.12% 214
2026
Q2 		$296K Buy
+883
New +$280K 0.11% 214
2025
Q1 		– Sell
-1,001
Closed -$77K – 697
2024
Q4 		$77K Sell
1,001
-1,296
-56% -$93.8K 0.03% 344
2024
Q3 		$132K Buy
2,297
+37
+2% +$2K 0.06% 341
2024
Q2 		$93.5K Buy
+2,260
New +$107K 0.05% 342
2022
Q2 		– Sell
-568
Closed -$87K – 466
2022
Q1 		$87K Sell
568
-34
-6% -$6.98K 0.04% 323
2021
Q4 		$178K Sell
602
-82
-12% -$24K 0.07% 255
2021
Q3 		$190K Sell
684
-36
-5% -$9.8K 0.08% 282
2021
Q2 		$197K Buy
+720
New +$258K 0.08% 354

Other funds holding PRAX

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.32T AUM 44.66% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
Pictet Asset Management
Pictet Asset Management Carouge, Switzerland $106B AUM 32.76% 1-Year Est. Return
GW&K Investment Management
GW&K Investment Management Boston, Massachusetts $11.8B AUM 29.45% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $765B AUM 28.39% 1-Year Est. Return
VOYA Investment Management
VOYA Investment Management Atlanta, Georgia $109B AUM 51.53% 1-Year Est. Return
Emerald Advisers
Emerald Advisers Leola, Pennsylvania $3.64B AUM 71.19% 1-Year Est. Return
Aberdeen Group
Aberdeen Group Edinburgh, United Kingdom $72.4B AUM 31.32% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $608B AUM 32.77% 1-Year Est. Return
Emerald Mutual Fund Advisers Trust
Emerald Mutual Fund Advisers Trust Leola, Pennsylvania $2.45B AUM 70.46% 1-Year Est. Return

Virtus ETF Advisers's PRAX Position: Q3 2026 in Review

Virtus ETF Advisers increased its Praxis Precision Medicines (PRAX) stake by 25% in Q3 2026, buying an estimated $73.5K and bringing the position to 1,105 shares worth $322K. The position accounts for 0.12% of the portfolio, ranked #214.

Virtus ETF Advisers first reported a position in PRAX in Q2 2021 and has held it in 9 quarters since. 152 funds tracked by Wall St. Rank hold PRAX as of Q3 2026.

  • Virtus ETF Advisers held 1,105 shares of Praxis Precision Medicines worth $322K as of Q3 2026.
  • Virtus ETF Advisers bought 222 Praxis Precision Medicines shares in Q3 2026, an estimated $73.5K.
  • Praxis Precision Medicines made up 0.12% of Virtus ETF Advisers's portfolio in Q3 2026, its #214 holding.
  • Virtus ETF Advisers first reported a position in Praxis Precision Medicines in Q2 2021 and has held it in 9 quarters since.
  • 152 funds tracked by Wall St. Rank held Praxis Precision Medicines as of Q3 2026.

Based on Virtus ETF Advisers's 13F filing for Q3 2026, filed 9 Nov 2026.